Found: 27
Select item for more details and to access through your institution.
Alcohol and Aldehyde Dehydrogenases Contribute to Sex-Related Differences in Clearance of Zolpidem in Rats.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00260
- By:
- Publication type:
- Article
Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 3, p. 896, doi. 10.3390/ijms21030896
- By:
- Publication type:
- Article
Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Phase l/lb Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 6, p. 1, doi. 10.1093/jnci/dju089
- By:
- Publication type:
- Article
Racial Disparities in the Association Between Variants on 8q24 and Prostate Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Oncologist, 2012, v. 17, n. 3, p. 312, doi. 10.1634/theoncologist.2011-0315
- By:
- Publication type:
- Article
Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020372
- By:
- Publication type:
- Article
Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 11, p. 1, doi. 10.1002/pbc.29282
- By:
- Publication type:
- Article
Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 4, p. 603, doi. 10.1002/pbc.25344
- By:
- Publication type:
- Article
More than an accessory: implications of type III transforming growth factor-β receptor loss in prostate cancer.
- Published in:
- BJU International, 2010, v. 105, n. 7, p. 913, doi. 10.1111/j.1464-410X.2009.08999.x
- By:
- Publication type:
- Article
Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.
- Published in:
- BJU International, 2008, v. 102, n. 11, p. 1694, doi. 10.1111/j.1464-410X.2008.07913.x
- By:
- Publication type:
- Article
Precision medicine applications in prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918776920
- By:
- Publication type:
- Article
Pharmacogenomics Implementation at the National Institutes of Health Clinical Center.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, p. S67, doi. 10.1002/jcph.993
- By:
- Publication type:
- Article
Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84960-w
- By:
- Publication type:
- Article
Induction of CYP3A4 by vinblastine: Role of the nuclear receptor NR1I2.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC)patients.
- Published in:
- BMC Cancer, 2010, v. 10, p. 511, doi. 10.1186/1471-2407-10-511
- By:
- Publication type:
- Article
Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1131, doi. 10.3390/cancers14051131
- By:
- Publication type:
- Article
Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0212097
- By:
- Publication type:
- Article
Drug-drug Interactions in Patients with HIV and Cancer in Sub-Saharan Africa.
- Published in:
- AIDS Reviews, 2021, v. 23, n. 1, p. 13, doi. 10.24875/AIDSRev.20000005
- By:
- Publication type:
- Article
A population pharmacokinetic/toxicity model for the reduction of platelets during a 48-h continuous intravenous infusion of the histone deacetylase inhibitor belinostat.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2010, v. 29, p. 95, doi. 10.1186/1756-9966-29-95
- By:
- Publication type:
- Article
Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 4, p. 461, doi. 10.1002/jcph.625
- By:
- Publication type:
- Article
UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 4, p. 450, doi. 10.1002/jcph.627
- By:
- Publication type:
- Article
Histone deacetylase inhibitors modulate K<sub>ATP</sub> subunit transcription in HL-1 cardiomyocytes through effects on cholesterol homeostasis.
- Published in:
- Frontiers in Pharmacology, 2015, p. 1, doi. 10.3389/fphar.2015.00168
- By:
- Publication type:
- Article
Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0152007
- By:
- Publication type:
- Article